Clopidogrel vs Ticagrelor Real-World Efficacy in Patients With ACS Managed With PCI
Differences in mortality and MACE were evaluated in patients with ACS managed with PCI who were receiving ticagrelor or clopidogrel.
Differences in mortality and MACE were evaluated in patients with ACS managed with PCI who were receiving ticagrelor or clopidogrel.
A study was conducted to determine clinical outcomes for patients who received CYP2C19-guided antiplatelet therapy after percutaneous coronary intervention.
Investigators sought to evaluate the long-term impact of intravascular ultrasound guided PCI in patients with acute myocardial infarction.
A study assessed the association between postprocedural anticoagulation therapy and multiple clinical outcomes in patients with STEMI.
A meta-analysis was conducted to compare short DAPT with de-escalation in patients with acute coronary syndrome who have received percutaneous coronary intervention.
Investigators evaluated the long-term incidence and influence of cardiovascular events prior to sudden death in stabilized patients following acute coronary syndrome.
Researchers evaluated the role of LDLR and APOA5 as biomarkers for early diagnosis of myocardial infarction.
Researchers conducted a systemic review to determine the effect of colchicine on patients with symptomatic coronary artery disease who have received PCI.
Researchers assessed whether integrating multiorgan focused clinical ultrasonography with the clinical evaluation of patients with a cardiopulmonary diagnosis would decrease hospital stay and costs.
Researchers sought to determine whether using high-sensitivity cardiac troponin T concentrations for suspected ACS could provide patients a safe and shorter stay in the hospital.